PBI
58
2
PEP
36
-3
CCI
28
2
R
68
-2
AXP
64
-2
AME
75
4
TXN
49
6
HCA
46
-2
MRO
55
5
HAL
53
5
CL
56
5
EXC
56
2
NOC
28
-13
VRTX
49
2
FSLR
46
2
DGX
50
2
AZO
55
6
PM
66
4
VLO
45
5
ACN
56
13
PBI
58
2
PEP
36
-3
CCI
28
2
R
68
-2
AXP
64
-2
AME
75
4
TXN
49
6
HCA
46
-2
MRO
55
5
HAL
53
5
CL
56
5
EXC
56
2
NOC
28
-13
VRTX
49
2
FSLR
46
2
DGX
50
2
AZO
55
6
PM
66
4
VLO
45
5
ACN
56
13
Financhill
Back

OncoCyte Vs. ProPhase Labs Industry Stock Comparison

Sell
37

OCX
OncoCyte

Last Price:
2.60
Seasonality Move:
36.67%
Sell
16

PRPH
ProPhase Labs

Last Price:
0.74
Seasonality Move:
14.29%
Sell
37
OncoCyte (OCX) is a Sell

Is OncoCyte a Buy, Sell or Hold?

  • The current OncoCyte [OCX] share price is $2.63. The Score for OCX is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • OCX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
16
ProPhase Labs (PRPH) is a Sell

Is ProPhase Labs a Buy, Sell or Hold?

  • The current ProPhase Labs [PRPH] share price is $0.79. The Score for PRPH is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
  • PRPH is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

OCX Stock Price Chart

What is OncoCyte's stock price today?

  • The OncoCyte share price today is $2.63
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and OCX is experiencing selling pressure, which indicates risk of future bearish movement.

PRPH Stock Price Chart

What is ProPhase Labs's stock price today?

  • The ProPhase Labs share price today is $0.79
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PRPH is experiencing buying pressure, which is a positive indicator for future bullish movement.

OCX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.09 Sell
Relative Strength Index (14 RSI): 31.8 Sell
Chaikin Money Flow: -5695 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.83 - 3.13) Sell
Bollinger Bands (100): (2.92 - 3.2) Sell

PRPH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.45 Sell
Relative Strength Index (14 RSI): 18.57 Sell
Chaikin Money Flow: 278291 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.13 - 2.53) Sell
Bollinger Bands (100): (1.87 - 3.25) Sell

OCX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.82 Sell
20-day SMA: 2.94 Sell
50-day SMA: 3.01 Sell
200-day SMA: 2.95 Sell
8-day EMA: 2.79 Sell
20-day EMA: 2.9 Sell
50-day EMA: 2.98 Sell
200-day EMA: 3.22 Sell

PRPH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.84 Sell
20-day SMA: 1.69 Sell
50-day SMA: 2.13 Sell
200-day SMA: 3.89 Sell
8-day EMA: 0.98 Sell
20-day EMA: 1.47 Sell
50-day EMA: 2.02 Sell
200-day EMA: 3.5 Sell

OncoCyte Earnings Growth & OCX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.17 per share, and an increase next year of $0.68 per share.

ProPhase Labs Earnings Growth & PRPH Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.49 per share, and an increase next year of $0.43 per share.

OncoCyte Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

ProPhase Labs Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):